Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion type Assertion NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_head.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion description "[We speculate that CYP1B1 inhibition in endometrial carcinomas could be a useful therapeutic approach as it regulates several potential anticancer targets like cyclin E1, Skp2, and TRAIL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_provenance.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion evidence source_evidence_literature NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_provenance.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion SIO_000772 19690133 NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_provenance.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion wasDerivedFrom befree-20150227 NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_provenance.
- NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_assertion wasGeneratedBy ECO_0000203 NP340368.RAsBKG4YNQaz6i5INhb-KZBVq2KqNZbRySnTsVENl2OtI130_provenance.